New drug successful to treat drug-resistant thyroid cancer
According to a study published inOncotarget, palbociclib, normally used in the treatment of breast cancer, can be used to treat papillary thyroid carcinomas that are resistant to vemurafenib.Medical Xpress
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Endocrinology | Study | Thyroid | Thyroid Cancer